VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
LTBR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
LTBRLightbridge Corporation
$8.66$224M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksLTBRFinancials

Lightbridge Corporation (LTBR) Financials

27Y historyFree accessUpdated daily

The company remains entirely pre-revenue, with operating losses widening to $6.3 million in 2026Q1 as R&D expenditures climbed to $3.3 million.

LTBR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Jun'05Jun'04Jun'03Jun'02Jun'01Jun'00Jun'99
Sales/Revenue000000000175.45K760.58K910.53K1.31M1.9M3.68M6.36M7.59M10.52M22.22M000003.71K173.53K173.53K0
Revenue Growth %---------100%-76.93%-16.47%-30.49%-31.09%-48.31%-42.13%-16.23%-27.85%-52.67%------100%-97.86%0%--
Cost of Goods Sold000000100.12K89.62K0107.09K456.56K694.29K756.28K1.11M2.27M3.99M4.94M6.23M11.09M11.76M13.15M22.7K00293.82K293.82K884.78K0
COGS % of Revenue---------61.04%60.03%76.25%57.73%58.39%61.64%62.81%65.12%59.22%49.91%-----7911.2%169.32%509.88%-
Gross Profit000000-100.12K-89.62K068.36K304.01K216.24K553.92K791.46K1.41M2.36M2.65M4.29M11.13M-11.76M-13.15M-13.15M00-290.11K-711K-711.25K0
Gross Margin %---------38.96%39.97%23.75%42.28%41.63%38.36%37.19%34.88%40.78%50.09%------7811.2%-409.73%-409.88%-
Gross Profit Growth %-----100%-11.71%--100%-77.52%40.59%-60.96%-30.01%-43.91%-40.31%-10.66%-38.29%-61.48%194.64%10.54%0%--100%59.2%0.03%--
Operating Expenses25.76M23.23M13.06M9.04M7.79M7.88M9.1M7.66M10.17M6.67M7.94M6.83M5.37M5.64M5.91M8.69M10.29M11.53M14.17M-11.82M12.32M2.86M95.43K92.23K0047.15K39.31K
OpEx % of Revenue---------3799.46%1043.81%750.55%409.92%296.95%160.58%136.75%135.56%109.62%63.79%-------27.17%-
Selling, General & Admin14.87M14.02M8.46M7.15M7.49M7.16M8.21M5.7M6.71M4.38M5.19M5.35M3.83M3.62M3.84M6.34M8.68M9.9M12.61M11M12.28M2.42M39.57K47.04K0014.57K10.95K
SG&A % of Revenue---------2498.2%682.51%587.57%292.75%190.27%104.43%99.8%114.38%94.1%56.74%-------8.4%-
Research & Development10.89M9.21M4.6M1.92M669.82K838.57K891.63K2.68M3.46M2.28M2.75M1.48M1.53M2.03M2.06M2.35M1.61M1.63M1.57M756.75K34.4K17.5K00001.86K0
R&D % of Revenue---------1301.26%361.3%162.98%117.18%106.68%56.14%36.97%21.19%15.52%7.05%-------1.07%-
Other Operating Expenses-1540-1K-31.03K-372.61K-119.64K0-715K000-6.76K-3.38K-3.49K4.56K000-5.65M-23.58M0442.81K55.86K45.19K0030.71K28.36K
Operating Income-18.08M-23.23M-13.06M-9.04M-7.79M-7.88M-9.2M-11.07M-10.17M-6.6M-7.63M-6.62M-4.82M-4.85M-4.5M-6.33M-7.64M-7.24M-3.04M11.76M-12.32M-2.69M-95.43K-142.23K-290.11K-290K-711.25K-39.31K
Operating Margin %----------3760.7%-1003.84%-726.83%-367.63%-255.29%-122.21%-99.56%-100.7%-68.85%-13.69%------7811.2%-167.12%-409.88%-
Operating Income Growth %--77.86%-44.43%-16.11%1.15%14.41%16.85%-8.81%-54.2%13.58%-15.37%-37.42%0.76%-7.96%28.97%17.17%-5.52%-138%-125.87%195.49%-357.5%-2720.92%32.91%50.97%-0.04%59.23%-1709.24%-
EBITDA-12.88M-19.58M-11.79M-9.04M-7.79M-8M-9.1M-10.98M000-8.92M-4.8M-4.84M-4.47M-6.3M-7.61M-7.21M-3.02M11.77M-12.31M-2.67M-54.73K-96.2K-253.31K-253.2K-710.65K-38.88K
EBITDA Margin %------------979.32%-366.32%-254.38%-121.44%-99.14%-100.34%-68.61%-13.58%------6820.41%-145.91%-409.53%-
EBITDA Growth %14.29%-66.12%-30.36%-16.11%2.62%12.16%17.09%---100%-85.82%0.77%-8.26%29.11%17.23%-5.52%-139.1%-125.64%195.65%-360.99%-4777.21%43.11%62.02%-0.04%64.37%-1727.84%-
D&A (Non-Cash Add-back)5.2M00000100.12K89.62K10.17M6.6M7.63M-2.3M17.22K17.22K28.36K26.96K27K25.48K24.67K8.58K10.89K22.7K40.7K46.04K36.8K36.8K603433
EBIT-16.98M-19.58M-11.79M-9.04M-7.79M-8M-14.42M-10.68M-14.69M-7.09M-6.32M-4.31M-4.82M-4.85M-4.5M-6.33M-7.64M-7.23M-3.04M-11.45M-11.71M-761K-974.68K0-253.65K-290K-711.25K-39.31K
Net Interest Income3.27M3.65M1.27M1.13M289.44K8.13K83.88K393.11K-724K-507K-220K-6.06K1.95K00465.16K193.21K22.42K162.89K00-370K000-36.2K00
Interest Income4.61M3.65M1.27M1.13M289.44K8.13K83.88K393.11K258.8K03167051.95K00465.16K193.21K22.42K162.89K072.44K72.44K000000
Interest Expense00000000982.44K507.31K220.79K6.76K0000000367.19K0442.81K0036.2K36.2K00
Other Income/Expense3.27M3.65M1.27M1.13M289.44K41.82K-5.21M393.11K-5.5M-507K1.29M2.3M1.16M266.17K438.2K459.14K76.23K6.59K193.04K7.33M608.06K339.64K050K266290.11K00
Pretax Income-21.15M-19.58M-11.79M-7.91M-7.5M-7.84M-14.42M-10.68M-15.68M-7.11M-6.34M-4.32M-4.82M-4.59M-4.06M-5.87M-7.56M-7.23M-2.85M11.64M-11.71M-2.35M0-92.23K-289.84K000
Pretax Margin %----------4049.68%-834.24%-474.23%-367.71%-241.29%-110.3%-92.34%-99.68%-68.78%-12.82%------7804.04%---
Income Tax0000000000001.43K23.25K0040.75K9.24K10.03K23.39M0-952K0150K-53236.42K00
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%-0.03%-0.51%0%0%-0.54%-0.13%-0.35%200.88%0%40.48%--162.63%0.18%---
Net Income-21.15M-19.58M-11.79M-7.91M-7.5M-7.84M-14.42M-10.68M-15.68M-7.11M-6.34M-4.32M-4.82M-4.87M-4.06M-5.87M-7.56M-7.23M-2.86M-11.45M-11.71M-2.69M-95.43K-142.23K-326.04K-326K-723.24K-39.31K
Net Margin %----------4049.68%-834.24%-474.23%-367.71%-255.92%-110.3%-92.34%-99.68%-68.78%-12.87%------8778.62%-187.87%-416.79%-
Net Income Growth %-53.98%-66.12%-49.04%-5.48%4.31%45.65%-35.03%31.89%-120.63%-11.98%-46.94%10.36%0.99%-19.92%30.87%22.4%-4.56%-152.99%75.04%2.18%-334.92%-2720.92%32.91%56.38%-0.01%54.93%-1739.74%-
Net Income (Continuing)-21.15M-19.58M-11.79M-7.91M-7.5M-7.84M-14.42M-10.68M-15.68M-7.11M-6.34M-4.32M-4.82M-4.87M-4.06M-5.87M-7.56M-7.23M-2.86M-11.45M-11.71M-761K-95.43K-142.23K-326.04K-326K-723.24K-39.31K
Discontinued Operations0000000000000000000000000000
Minority Interest0000000000000000000000000000
EPS (Diluted)-0.66-0.80-0.81-0.65-0.69-1.71-3.59-2.21-7.06-8.18-16.10-14.16-14.40-21.00-19.49-28.45-40.80-43.31-17.40-69.49-160.11-84.72-4.48-7.11-17.39-18.00-84.20-4.70
EPS Growth %11.49%1.23%-24.62%5.8%59.65%52.37%-62.44%68.7%13.69%49.19%-13.7%1.67%31.43%-7.75%31.49%30.27%5.8%-148.91%74.96%56.6%-88.99%-1791.07%36.99%59.11%3.39%78.62%-1691.49%-
EPS (Basic)--0.80-0.81-0.65-0.69-1.71-3.59-2.21-7.06-8.18-16.10-14.16-14.40-21.00-19.49-28.45-40.76-43.31-17.15-69.49-160.11-84.72-4.48-7.11-17.39-18.00-54.00-4.70
Diluted Shares Outstanding32.04M24.52M14.49M12.1M10.84M7.04M4.22M3.11M2.22M868.7K394.08K303.99K257.72K216.82K208.18K206.27K185.56K167.02K166.71K164.81K73.13K31.77K21.32K20.02K18.75K18.75K8.59K8.37K
Basic Shares Outstanding32.04M24.52M14.49M12.1M10.84M7.04M4.22M3.11M2.22M868.7K394.08K303.99K257.72K216.82K208.18K206.27K185.56K167.02K166.71K164.81K73.13K31.77K21.32K20.02K18.75K18.75K8.59K8.37K
Dividend Payout Ratio----------------------------

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetFortress
Cash FlowBurning
Top Statement Risk

Regulatory and HALEU dependency

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Escalating R&D Expenditure Trends

As indicated by recent quarterly filings, Lightbridge's R&D spending has trended upward, reaching $3.3 million in 2026Q1 compared to $555.2 thousand in 2023Q4, reflecting the intensifying capital requirements necessary to advance its proprietary metallic fuel rod technology through critical regulatory and irradiation testing phases.

The consistent rise in R&D costs suggests that the company is accelerating its technical validation efforts, likely in response to NRC requirements. Investors should monitor whether this spending trajectory correlates with tangible progress in Lead Test Assembly milestones or if it merely reflects the rising cost of specialized nuclear testing services.

Operating Leverage Remains Non-Existent

Based on the company's reported financial statements, Lightbridge continues to operate without revenue, resulting in a persistent operating loss that widened to $6.3 million in 2026Q1, highlighting the lack of operational leverage inherent in a pre-commercial research and development business model.

Because the company lacks a commercial product, operating expenses directly translate into net losses without any offsetting gross profit. This structure implies that the company's financial health is entirely decoupled from operational efficiency and remains tethered to its ability to manage cash burn until a licensing model is realized.

Dilution Impacts Earnings Quality

According to historical financial data, Lightbridge's net loss per share has been consistently impacted by equity-based compensation and potential dilution, with stock-based compensation reaching $2.5 million in 2026Q1, which complicates the assessment of true economic loss for shareholders.

The reliance on equity issuance to fund operations suggests that shareholders should be wary of the impact of dilution on future per-share value. The high level of stock-based compensation relative to the total R&D spend warrants further investigation into management's alignment with long-term commercialization milestones versus short-term capital raising.

Commercialization Risks and HALEU Bottlenecks

While the company maintains a strong cash position, the lack of revenue generation, as noted in recent SEC filings, underscores the significant risk that Lightbridge may remain a pre-revenue entity indefinitely if domestic HALEU supply chain constraints are not resolved in the near term.

Short-sellers would likely focus on the 'HALEU trap,' where the company's fuel design remains theoretically sound but practically unusable due to the absence of necessary enrichment infrastructure. This suggests that even with a $201.8 million cash balance, the company's ultimate viability is contingent upon external factors outside of its direct control.

LTBR — Frequently Asked Questions

Quick answers to the most common questions about buying LTBR stock.

What was Lightbridge Corporation's (LTBR) revenue in 2025?

For fiscal year 2025, Lightbridge Corporation (LTBR) reported total revenue of $0.0M.

Is Lightbridge Corporation (LTBR) profitable?

Lightbridge Corporation (LTBR) reported a net loss of $19.6M for the fiscal year ending 2025.